NDC product
Neomycin and Polymyxin B Sulfates and Bacitracin Zinc
NDC 16571-754 · Rising Pharma Holdings, Inc.
Key facts
| Product NDC | 16571-754 |
|---|---|
| Proprietary name | Neomycin and Polymyxin B Sulfates and Bacitracin Zinc |
| Labeler | Rising Pharma Holdings, Inc. |
| Marketing category | NDA AUTHORIZED GENERIC |
| Application number | NDA050417 |
| Marketing start | Apr 7, 2017 |
| Marketing end | Oct 1, 2024 |
| Listing certified through | Oct 1, 2024 |
At a glance
- 1–9 Package NDCs
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About National Drug Codes (NDC)
The National Drug Code (NDC) is the FDA's product identifier for drugs; the product NDC identifies the labeler and product, and each package adds a package code.
Source: U.S. Food and Drug Administration (FDA), National Drug Code Directory · Source date: